https://www.business-standard.com/markets/capital-market-news/sanofi-india-cipla-join-hands-to-promote-cns-products-in-india-124032700220_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-to-promote-distribute-sanofi-vaccine-brands-in-india/articleshow/108824493.cms
https://www.globenewswire.com//news-release/2024/03/15/2847265/0/en/Sanofi-Information-concerning-the-total-number-of-voting-rights-and-shares-February-2024.html
https://www.fiercebiotech.com/biotech/sanofi-shutting-down-rd-site-uk-displacing-90-workers
https://www.clinicaltrialsarena.com/news/sanofis-amlitelimab-shows-best-in-class-response-in-atopic-dermatitis/
https://www.globenewswire.com//news-release/2024/03/11/2843456/0/en/Press-Release-New-Phase-2b-results-for-amlitelimab-support-potential-for-best-in-class-maintenance-of-response-in-atopic-dermatitis.html
https://www.reuters.com/business/healthcare-pharmaceuticals/compounded-semaglutide-poses-serious-us-health-issue-novo-nordisk-ceo-says-2024-03-08/
https://www.reuters.com/business/healthcare-pharmaceuticals/astra-sanofis-rsv-therapy-highly-effective-against-infant-hospitalizations-cdc-2024-03-07/
https://www.globenewswire.com/news-release/2024/02/24/2834723/0/en/Press-Release-Phase-2-results-demonstrate-rilzabrutinib-rapidly-reduced-itch-severity-and-significantly-improved-disease-activity-in-adults-with-chronic-spontaneous-urticaria.html
https://www.globenewswire.com//news-release/2024/02/23/2834600/0/en/Press-Release-Filing-of-the-2023-U-S-Form-20-F-and-French-Document-d-Enregistrement-Universel-containing-the-Annual-Financial-Report.html